Failures in assisted reproductive technology: An overview

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 107, Issue 1, 2003, Pages 4-18

  Fasouliotis, Sozos J ^a   Schenker, Joseph G ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CRYOPRESERVATION; EMBRYO TRANSFER; FERTILIZATION IN VITRO; HUMAN; INFERTILITY; MATERNAL AGE; NIDATION; OOCYTE; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PRIORITY JOURNAL; REPRODUCTION; REVIEW;

EID: 0037467453     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(02)00309-3     Document Type: Article

References (135)

1. Fasouliotis S.J., Schenker J.G. A historical perspective of the clinical evolution of the assisted reproductive technologies. Gynecol. Endocrinol. 13:1999;420-440.
2. Krey L.C., Grifo J.A. Poor embryo quality: the answer lies (mostly) in the egg. Fertil. Steril. 75:2001;466-468.
3. Alsalili M., Yuzpe A., Tummon I.et al. Cumulative pregnancy rates and pregnancy outcome after in vitro fertilization: <5000 cycles at one center. Hum. Reprod. 10:1995;470-474.
4. Kovacs G.T. The likelihood of pregnancy with IVF and GIFT in Australia and New Zealand. Med. J. Aust. 158:1996;805-807.
5. Ezra Y., Schenker J.G. Appraisal of in vitro fertilization. Eur. J. Obstet. Gynecol. Reprod. Biol. 48:1993;127-133.
6. Human Fertilization and Embryology Authority (HFEA). Annual Report, 2000.
7. Society for Assisted Reproductive Technology and the American Society for Reproductive Medicine. Assisted Reproductive Technology in the United States: 1998 results generated from the American Society for Reproductive Medicine and Society for Assisted Reproductive Technology. Fertil Steril 200;277:18-31.
8. De Mouzon J., Lancaster P. World collaborative report on IVF: preliminary data for 1995. J. Assist. Reprod. Genet. 14(Suppl):1997;251S-265S.
9. Nygren K.G., Andersen A.N. The European IVF-monitoring programme (EIM), for the European Society of Human Reproduction and Embryology (ESHRE). Assisted reproductive technology in Europe, 1998. Results generated from European registers by ESHRE. Hum. Reprod. 16:2001;2459-2471.
10. Zegers F. The Latin American way. Orgyn. 4:1998;53-56.
11. Pellicer A., Lightman A., Diamond M.P., Russell J.B., DeCherney A.H. Outcome of in vitro fertilization in women with low response to ovarian stimulation. Fertil. Steril. 47:1987;812-815.
12. Laufer N, Navot D, Human in vitro fertilization. In: DeCherney AH, editor. Reproductive failure. 1st ed. New York: Churchill Livingstone, 1986. p. 219-46.
13. Garcia J., Jones G.S., Acosta A.A., Wright G.L. Jr. Human menopausal gonadotropin/human chorionic gonadotropin follicular maturation for oocyte aspiration: phase II, 1981. Fertil. Steril. 39:1983;174-179.
14. Hanoch J., Lavy Y., Holzer H., Hurwitz A., Simon A., Revel A., Laufer N. Young low responders protected from untoward effects of reduced ovarian response. Fertil. Steril. 69:1998;1001-1004.
15. Muasher S.J. Controversies in assisted reproduction: treatment of low responders. J. Assist. Reprod. Genet. 10:1993;112-114.
16. Cameron I.T., O'Shea F.C., Rolland J.M., Hughes E.G., De Kretser D.M., Healy D.L. Occult ovarian failure: a syndrome of infertility, regular menses, and elevated follicle-stimulating hormone concentrations. J. Clin. Endocrinol. Metab. 67:1988;1190-1194.
17. Pellicer A., Ballester M.J., Serrano M.D., Mir A., Serra-Serra V., Remohi J.et al. Aetiological factors involved in the low response to gonadotropins in infertile women with normal basal serum follicle stimulating hormone levels. Hum. Reprod. 9:1994;806-811.
18. Scott R.T. Jr., Hofmann G.E. Prognostic assessment of ovarian reserve. Fertil. Steril. 63:1995;1-11.
19. Fasouliotis S.J., Simon A., Laufer N. Evaluation and treatment of low responders in assisted reproductive technology: a challenge to meet. J. Assist. Reprod. Genet. 17:2000;357-373.
20. Fisch B., Royburt M., Pinkas H., Avrech O.M., Goldman G.A., Bar J.et al. Augmentation of low ovarian response to superovulation before in vitro fertilization following priming with contraceptive pills. Isr. J. Med. Sci. 32:1996;1172-1176.
21. Hughes S.M., Huang Z.H., Morris I.D., Matson P.L., Buck P., Lieberman B.A. A double-blind cross-over study to evaluate the effect of human biosynthetic growth hormone on ovarian stimulation in previous poor responders to in vitro fertilization. Hum. Reprod. 9:1994;13-18.
22. Bider D., Blankstein J., Levron J., Tur-Kaspa I. Gonadotropins and glucocorticoid therapy for "low responders": a controlled study. J. Assist. Reprod. Genet. 14:1997;328-331.
23. Daya S. Gonadotropin-releasing hormone agonist protocols for pituitary desensitization in in vitro fertilization and gamete intrafallopian transfer cycles. In: The cochrane library, Issue 2. Oxford Update Software, 2002 [cochrane review].
24. Nikolettos N., Al-Hasani S., Felberbaum R.et al. Gonadotropin-releasing hormone antagonist protocol: a novel method of ovarian stimulation in poor responders. Eur. J. Obstet. Gynecol. Reprod. Biol. 97:2001;202-207.
25. Al-Ilany H., Aboulghar M., Gonadotropin-releasing hormone antagonists for assisted conception. In: The cochrane library, Issue 2. Oxford Update Software, 2002 [cochrane review].
26. Tarin JJ, BrinesJ, Cano A, Long-term effects of delayed parenthood, Hum Reprod 1998;2371-76.
27. Federation CECOS (Schwartz D, Mayaux MJ). Female fecundity as a function of age: results of an artificial insemination in 2193 nulliparous women with azoospermic husbands. N Engl J Med 1982;306:404-06.
28. Piette C., De Mouzon J., Bachelor A. In vitro fertilization: influence of women's age on pregnancy rates. Hum. Reprod. 5:1990;56-59.
29. Spandorfer S.D., Chung P.H., Kligman I., Liu H.C., Davis O.K., Rosenwaks Z. An analysis of the effect of age on implantation rates. J. Assist. Reprod. Genet. 17:2000;303-306.
30. Wood C., Calderon I., Crombie A. Age and fertility: results of assisted reproductive technology in women over 40 years. J. Assist. Reprod. Genet. 9:1992;482-484.
31. Templeton A., Morris J.K., Parslow W. Factors that affect outcome of in vitro fertilization treatment. Lancet. 348:1996;1402-1406.
32. Spandorfer S.D., Rosenwaks Z. The impact of maternal age and ovarian age on fertility. Postgraduate Obstet. Gynecol. 20:2000;1-6.
33. Bopp B.L., Alper M.M., Thompson I.E.et al. Success rates with gamete intrafallopian transfer and in vitro fertilization in women of advanced maternal age. Fertil. Steril. 63:1995;1278-1283.
34. Homburg R., Berkowitz D., Levy T.et al. In vitro fertilization and embryo transfer for the treatment of infertility associated with polycystic ovary syndrome. Fertil. Steril. 60:1993;858-863.
35. Nackley A.C., Muasher S.J. The significance of hydrosalpinx in in vitro fertilization. Fertil. Steril. 69:1998;373-384.
36. Lessey B.A. Medical management of endometriosis and infertility. Fertil. Steril. 23:2000;1089-1096.
37. Oehninger S., Acosta A.A., Kreiner D.et al. In vitro fertilization and embryo transfer: an established and successful therapy for endometriosis. J. In vitro Fertil. Embryo Trans. 5:1988;249-256.
38. Damario M.A., Moy F., Moomjy M.et al. Delay of gonadotropin stimulation in patients receiving gonadotropin-releasing hormone-agonist (GnRH-a) therapy permits increased clinic efficiency and may enhance in vitro fertilization (IVF) pregnancy rates. Fertil. Steril. 68:1997;1004-1010.
39. Kim C.H., Cho Y.K., Mok J.E. Simplified ultralong protocol of gonadotropin releasing hormone-agonist for ovulation induction with intrauterine insemination in patients with endometriosis. Hum. Reprod. 11:1996;398-402.
40. Dmowski W.P., Rana N., Michalowska J.et al. The effect of endometriosis, its stage and activity, and of autoantibodies on in vitro fertilization and embryo transfer success rates. Fertil. Steril. 63:1995;555-562.
41. Oliveness F., Feldberg D., Liu H.C.et al. Endometriosis: a stage by stage analysis, the role of in vitro fertilization. Fertil. Steril. 64:1995;392-398.
42. Pal L., Shifren J.L., Isaacson K.B.et al. Impact of varying stages of endometriosis on the outcome of in vitro fertilization-embryo transfer. J. Assist. Reprod. Genet. 15:1998;27-31.
43. Jenkins J.M., Mathur R.S., Cooke I.D. The management of severe ovarian hyperstimulation syndrome. Br. J. Obstet. Gynecol. 102:1995;2-5.
44. Navot D., Bergh P.A., Laufer N. Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil. Steril. 58:1992;249-261.
45. Abramov Y., Schenker J.G., Lewin A., Friedler S., Barak V. Plasma inflammatory cytokines correlate to the ovarian hyperstimulation syndrome. Hum. Reprod. 11:1996;1381-1386.
46. Awonuga A., Govindbhai J., Zierke S., Schnauffer K. Continuing the debate on empty follicle syndrome: can it be associated with normal bioavailability of β-human chorionic gonadotropin on the day of oocyte retrieval? Hum. Reprod. 13:1998;1281-1284.
47. Zreik T.G., Garcia-Velasco J.A., Vergara T.M., Arici A., Olive D., Jones E.E. Empty follicle syndrome: evidence for recurrence. Hum. Reprod. 15:2000;999-1002.
48. Ndukwe G., Thornton S., Fischel S.et al. Predicting empty follicle syndrome. Fertil. Steril. 66:1996;845-847.
49. Meniru G., Craft I. Evidence from a salvaged treatment cycle supports an aetiology for the empty follicle syndrome that is related to terminal follicular developmental events. Hum. Reprod. 12:1997;2385-2387.
50. Dicker D., Ashkenazi J., Feldberg D.et al. Severe abdominal complications after transvaginal ultrasonographically guided retrieval of oocytes for in vitro fertilization and embryo transfer. Fertil. Steril. 59:1993;1313-1315.
51. Payne D., Matthews C.D. Intracytoplasmic sperm injection: clinical results from the Reproductive Medicine Unit, Adelaide. Reprod. Fertil. Dev. 7:1995;219-227.
52. Flaherty S.P., Payne D., Matthews C.D. Fertilization failures and abnormal fertilization after intracytoplasmic sperm injection. Hum. Reprod. 13(Suppl):1998;155-164.
53. Flaherty SP, Payne D, Matthews CD. Fertilization failures after ICSI. In: Filicori M, Flamigni C, editors. Treatment of infertility: the new frontiers. Communications Media for Education, 1998. p. 269-82.
54. Speroff L, Glass RH, Kase NG. Assisted Reproduction. In: Clinical gynecologic endocrinology and infertility. 6th ed. Lippincott Williams & Wilkins, 1999. p. 1133-48.
55. Van Voorhis B.J., Syrop C.H., Allen B.D.et al. The efficacy and cost effectiveness of embryo cryopreservation compared with other assisted reproductive techniques. Fertil. Steril. 64:1995;647-650.
56. Ludwig M., Al-Hasani S., Felberbaum R.et al. New aspects of cryopreservation of oocytes and embryos in assisted reproduction and future perspectives. Hum. Reprod. 14(Suppl 1):1999;162-185.
57. Horne G., Critchlow J.D., Newman M.C.et al. A prospective evaluation of cryopreservation strategies in a two-embryo transfer programme. Hum. Reprod. 12:1997;542-547.
58. Fasouliotis S.J., Schenker J.G. Cryopreservation of embryos: medical, ethical and legal issues. J. Assist. Reprod. Genet. 13:1996;756-761.
59. Edwards R.G., Beard H.K. Is the success of human IVF more a matter of genetics and evolution than growing blastocysts? Hum. Reprod. 14:1999;1-6.
60. Schoolcraft WB. Embryo transfer. In: Gardner DK, Weissman A, Howles CM, Shoham Z, eds. Textbook of Assisted Reproductive Techniques: Laboratory and Clinical Perspectives. Martin Dunitz, 2001. p. 623-6.
61. Schoolcraft W.B., Surrey E.S., Gardner D.K. Embryo transfer: techniques and variables affecting success. Fertil. Steril. 76:2001;863-870.
62. Lewin A., Schenker J.G., Avrech O., Shapira S., Safran A.M., Friedler S. The role of uterine straightening by passive bladder distention before embryo transfer in IVF cycles. J. Assist. Reprod. Genet. 14:1987;32-34.
63. Toth T.L., Oehninger S., Toner J.P., Brzyski R.G., Acosta A.A., Muasher S.J. Embryo transfer to the uterus or the fallopian tube after in vitro fertilization yields similar results. Fertil. Steril. 57:1992;1110-1113.
64. Elsner C.W., Tucker M.J., Sweitzer C.L. Multiple pregnancy rate and embryo number transferred during in vitro fertilization. Am. J. Obstet. Gynecol. 177:1997;350-357.
65. Walters D.E. The statistical implication of the "number of replacements" in embryo transfer. Hum. Reprod. 11:1996;10-12.
66. Coetsier T., Dhont M. Embryo transfer and multiple gestation. Avoiding multiple pregnancies in in vitro fertilization: who is afraid of single embryo transfer? Hum. Reprod. 13:1998;2663-2664.
67. Murdoch A.P. Embryo transfer and multiple gestation. How many embryos should be transferred? Hum. Reprod. 10:1998;2666-2670.
68. ESHRE Capri Workshop. Infertility revisited: the state of the art today and tomorrow. Hum Reprod 1996;11:1779-807.
69. Bronson R. How should the number of embryos transferred to the uterus following in vitro fertilization be determined to avoid the risk of multiple gestation? Hum. Reprod. 12:1997;1605-1607.
70. Bavister B.D. Culture of preimplantation embryos: facts and artifacts. Hum. Reprod. Update. 1:1995;91-148.
71. Bavister B.D., Boatman D.E. The neglected human blastocyst revisited. Hum. Reprod. 12:1997;1607-1610.
72. Trounson A., Pushett D., MacLellan L.J.et al. Current status of IVM/IVF and embryo culture in human and farm animals. Theriogenology. 41:1994;57-66.
73. Hasler J.F., Henderson W.B., Hurtgen P.J.et al. Production, freezing and transfer of bovine IVF embryos and subsequent calving results. Theriogenology. 43:1995;141-152.
74. Scholtes M., Zeilmaker G. A prospective randomized study of embryo transfer results after 3 or 5 days of embryo culture in in vitro fertilization. Fertil. Steril. 65:1996;1245-1248.
75. Gardner D.K., Vella P., Lane M.et al. Culture and transfer of human blastocysts increases implantation rates and reduces the need for multiple embryo transfers. Fertil. Steril. 69:1998;84-88.
76. Gardner D.K., Schoolcraft W.B., Wagley L.et al. A prospective randomized trial of blastocyst culture and transfer in in vitro fertilization. Hum. Reprod. 13:1998;3434-3440.
77. Jones G.M., Trounson A.O., Gardner D.K., Kausche A., Lolatgis N., Wood C. Evolution of a culture protocol for successful blastocyst development and pregnancy. Hum. Reprod. 13:1998;169-177.
78. Jones G.M., Trounson A.O., Lolatgis N., Wood C. Factors affecting the success of human blastocyst development and pregnancy following in vitro fertilization and embryo transfer. Fertil. Steril. 70:1998;1022-1029.
79. Rijnders P.M., Jansen C.A.M. The predictive value of day 3 embryo morphology regarding blastocyst formation, pregnancy and implantation rate after day 5 transfer following in vitro fertilization or intracytoplasmic sperm injection. Hum. Reprod. 13:1998;2869-2873.
80. Alves da Motta E.L., Alegretti J.R., Baracat E.C., Olive D., Serafini P.C. High implantation and pregnancy rates with transfer of human blastocysts developed in preimplantation stage one and blastocyst media. Fertil. Steril. 70:1998;659-663.
81. Bongso A., Fong C.Y., Ng S.C.et al. Co-culture techniques for blastocyst transfer and embryonic stem cell production. Assist. Reprod. Rev. 5:1995;106-114.
82. Lopata A. Implantation of the human embryo. Hum. Reprod. 11(Suppl):1996;175-184.
83. Cohen J., Alikani M., Trowbridge J., Rosenwaks Z. Implantation enhancement by selective assisted hatching using zona drilling of human embryos with poor prognosis. Hum. Reprod. 5:1992;685-691.
84. Mandelbaum J. The effects of assisted hatching on the hatching process and implantation. Hum. Reprod. 11(Suppl):1996;43-50.
85. Anderson TL. Biochemical markers for the window of uterine receptivity. In: Boston: Adams Publishing Group, 1993. p. 219-24.
86. Steptoe P.C., Edwards R.G. Reimplantation of a human embryo with subsequent tubal pregnancy. Lancet. 1:1976;880-882.
87. Marcus S.F., Macnamme M., Brinsden P. The prediction of ectopic pregnancy after IVF-ET. Hum. Reprod. 10:1995;2165-2168.
88. Lewin A, Schenker JG. Conception following assisted reproduction techniques. In: Kurjak A, editor. Textbook of perinatal medicine. Carnforth: Parthenon Publishing Group, 1998. p. 204-25.
89. Rufat P., Olivennes F., De Mouzon J.et al. Task force report on the outcome of pregnancies and children conceived by in vitro fertilization. Fertil. Steril. 61:1994;324-330.
90. Olivennes F., Fanchin R., Ledee N.et al. Perinatal outcome and developmental studies on children born after IVF. Hum. Reprod. Update. 8:2002;117-128.
91. Verlaenen H., Cammu H., Derde M.P.et al. Singleton pregnancy after in vitro fertilization: expectations and outcome. Obstet. Gynecol. 86:1995;906-910.
92. Olivennes F., Rufat P., Andre B.et al. The increased risk of complication observed in singleton pregnancies resulting from in vitro fertilization does not seem to be related to the IVF method itself. Hum. Reprod. 8:1993;1297-1300.
93. Tanbo T., Dale P.O., Lunde O.et al. Obstetric outcome in singleton pregnancies after assisted reproduction. Obstet. Gynecol. 86:1995;188-192.
94. Reubinoff B., Samueloff A., Ben-Haim M.et al. Is the obstetrical outcome of in vitro fertilized singleton gestations different from natural ones? A controlled study. Fertil. Steril. 67:1997;1077-1083.
95. Lieberman B. Embryo transfer and multiple gestation: an embryo too many? Hum. Reprod. 13:1998;2664-2666.
96. Mugford M, Henderson J. Resource implications of multiple births. In: Ward HR, Whittle M, editors. Multiple births. London (UK): RCOG, 1995. p. 334-45.
97. Doyle P. The outcome of multiple pregnancy. Hum. Reprod. 11(Suppl 1):1996;110-120.
98. Gonen R., Heyman E., Asztalos E.V.et al. The outcome of triplet, quadruplet and quintuplet pregnancies managed in a perinatal unit: obstetrics, neonatal and follow-up data. Am. J. Obstet. Gynecol. 2:1990;454-459.
99. Fasouliotis S.J., Schenker J.G. Multifetal pregnancy reduction: a review of the world results for the period 1993-1996. Eur. J. Obstet. Gynecol. Reprod. Biol. 75:1997;183-190.
100. Wisanto A., Magnus M., Bonduelle M.et al. Obstetric outcome of 424 pregnancies after intracytoplasmic sperm injection. Hum. Reprod. 10:1995;2713-2718.
101. Wennerholm U.B., Bergh C., Hamberger L.et al. Obstetric and perinatal outcome of pregnancies following intracytoplasmic sperm injection. Hum. Reprod. 11:1996;1113-1119.
102. Govaerts I., Devreker F., Koenig I.et al. Comparison of pregnancy outcome after intracytoplasmic sperm injection and in vitro fertilization. Hum. Reprod. 13:1998;1514-1518.
103. Govaerts I., Koenig I., Van den Bergh M.et al. Is intracytoplasmic sperm injection a safe procedure? What do we learn from early pregnancy data in ICSI? Hum. Reprod. 11:1996;440-443.
104. Tarlatzis B.C., Grimbizis G. Pregnancy and child outcome after assisted reproduction techniques. Hum. Reprod. 14(Suppl):1999;231-242.
105. Ludwig M., Al-Hasani S., Felberbaum R.et al. Safety of embryo cryopreservation: statistical facts and artefacts. No impacts of cryopreservation and thawing on embryo developmental potential, one more example for the problems of retrospective, non-controlled data. Hum. Reprod. 13:1998;786-787.
106. Wada I., Matson P.L., Troup S.A.et al. Outcome of treatment subsequent to the elective cryopreservation of all embryos from women at risk of the ovarian hyperstimulation syndrome. Hum. Reprod. 7:1992;962-966.
107. American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry. Assisted Reproductive Technology in the United States and Canada: 1995 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry. Fertil Steril 1998;69:389-98.
108. Wang X.J., Ledger W., Payne D.et al. The contribution of embryo cryopreservation to in vitro fertilization/gamete intrafallopian transfer: 8 years experience. Hum. Reprod. 9:1994;103-109.
109. Pados G., Camus M., Van Steirteghem A.et al. The evaluation and outcome of pregnancies from oocyte donation. Hum. Reprod. 9:1994;538-542.
110. Tan S.L., Doyle P., Campbell S.et al. Obstetric outcome of in vitro fertilization pregnancies compared with normally conceived pregnancies. Am. J. Obstet. Gynecol. 167:1992;778-784.
111. Lancaster P.A.L. Congenital malformations after in vitro fertilization. Lancet. 2:1987;1392-1393.
112. Cohen J., Mayaux M.J., Guilhard-Moscato L. Pregnancy outcomes after in vitro fertilization: a collaborative study on 2342 pregnancies. Ann. New York Acad. Sci. 541:1988;1-6.
113. Morin N.C., Wirth F.H., Johnson D.H.et al. Congenital malformations and psychosocial development in children conceived by in vitro fertilization. J. Pediatr. 115:1989;222-227.
114. Brandes J.M., Scher A., Izkovites J.et al. Growth and development of children conceived by in vitro fertilization. Pediatrics. 90:1992;424-429.
115. D'Souza S.W., Rivlin E., Cadman J.et al. Children conceived by in vitro fertilization after fresh embryo transfer. Arch. Dis. Child. 76:1997;F70-F74.
116. Addor V., Santos-Eggimann B., Fawer C.L.et al. Impact of infertility treatments on the health of newborns. Fertil. Steril. 69:1998;210-215.
117. Olivennes F., Kerbrat V., Rufat P.et al. Follow-up of a cohort of 422 children aged 6-13 years conceived by IVF. Fertil. Steril. 67:1997;284-289.
118. Wennerholm U.B., Janson P.O., Wennergren M.et al. Pregnancy complications and short-term follow-up of infants born after in vitro fertilization and embryo transfer (IVF/ET). Acta Obstet. Gynecol. Scand. 70:1991;565-573.
119. Johnson M.D. Genetic risks of intracytoplasmic sperm injection in the treatment of male infertility: recommendations for genetic counseling and screening. Fertil. Steril. 70:1998;397-411.
120. Palermo G.D., Colombero L.T., Schattman G.L.et al. Evolution of pregnancies and initial follow-up of newborns delivered after intracytoplasmic sperm injection. J. Am. Med. Assoc. 276:1996;1893-1897.
121. Bonduelle M., Wilikens A., Buysse A.et al. A follow-up study of children born after intracytoplasmic sperm injection (ICSI) with epididymal and testicular spermatozoa and after replacement of cryopreserved embryos obtained after ICSI. Hum. Reprod. 13(Suppl 1):1998;196-203.
122. Tarlatzis B.C., Bili H. Survey on intracytoplasmic sperm injection: report from the ESHRE ICSI Task Force. European Society of Human Reproduction & Embryology. Hum. Reprod. 13(Suppl 1):1998;165-177.
123. In't-Veld P., Brandenburg H., Verhoeff A.et al. Sex chromosomal abnormalities and intracytoplasmic sperm injection. Lancet. 346:1995;773.
124. Liebaers I., Bonduelle M., Van Assche E.et al. Sex-chromosome abnormalities and intracytoplasmic sperm injection. Lancet. 346:1995;1095. [Letter to the editor].
125. Bonduelle M., Aytoz A., Van Assche E.et al. Incidence of chromosomal aberrations in children born after assisted reproduction through intracytoplasmic sperm injection. Hum. Reprod. 13:1998;781-782.
126. Nielsen J., Wohlert M. Chromosome abnormalities found among 34910 newborn children: results from a 13-year study in Arhus, Denmark. Hum. Genet. 87:1991;81-83.
127. Van Opstal D., Los F., Ramlakhan S.et al. Determination of the parent of origin in nine cases of prenatally detected chromosome aberrations found after intracytoplasmic sperm injection. Hum. Reprod. 12:1997;682-686.
128. Bowen J.R., Gibson F.L., Leslie G.I.et al. Medical and developmental outcome at 1 year for children conceived by intracytoplasmic sperm injection. Lancet. 351:1998;1529-1534.
129. Bonduelle M., Joris H., Hofmans K., Liabaers I., Van Steirteghem A. Mental development of 201 ICSI children at 2 years of age. Lancet. 351:1998;1553.
130. Porreco R.P. Perinatal costs of assisted reproductive technology. Obstet. Gynecol. Surv. 53:1998;393-394.
131. Neumann P.J., Gharib S.D., Weinsterin M.C. The cost of a successful delivery with in vitro fertilization. N. Engl. J. Med. 331:1994;239-243.
132. Stovall D.W., Sparks A.E.T., Syrop C.H., Saunders R.G., Van Voorhis B.J. The cost of infertility evaluation and therapy: findings of a self-insured university healthcare plan. Fertil. Steril. 72:1999;778-784.
133. Goldfarb J.M., Austin C., Lisbona H.et al. Cost-effectiveness of in vitro fertilization. Obstet. Gynecol. 87:1996;18-21.
134. Hughes E.G., Giacomini M. Funding in vitro fertilization treatment for persistent subfertility: the pain and the politics. Fertil. Steril. 76:2001;431-442.
135. Fasouliotis S.J., Schenker J.G. Social aspects in assisted reproduction. Hum. Reprod. Update. 5:1999;26-39.